Ikarian Capital »

Direxion Shs Etf Tr shares owned by Ikarian Capital

Quarter-by-quarter ownership of Direxion Shs Etf Tr shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Direxion Shs Etf Tr

Tip: Access up to 7 years of quarterly data

All positions including Direxion Shs Etf Tr held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Direxion Shs Etf Tr by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.7M 92k 40.44

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Direxion Shs Etf Tr

Susquehanna International
Bnp Paribas Arbitrage, Snc
Ikarian Capital
Citadel Advisors
Jane Street
Wolverine Trading
Qube Research & Technologies
Boothbay Fund Management
Tower Research Capital
Virtu Financial
Two Sigma Securities
Scientech Research
Hrt Financial
Jpmorgan Chase & Co
Csenge Advisory Group

View all funds holding Direxion Shs Etf Tr